Escalating Need to Reduce Drug Development Costs and Time to Fuel AI Enabled Drug Discovery & Clinical Trials Market A new study by MarkNtel Advisors, the Global AI Enabled Drug Discovery & Clinical Trials Market is likely to witness around 23.6% CAGR during 2021-26. UNITED SATES, July 29, 2021 /EINPresswire.com/ -- It owes primarily to the rapidly increasing awareness regarding the benefits of AI among medical professionals, the mounting requirements to minimize the drug discovery cost & time, and burgeoning adoption of cloud-based services & applications, owing to which, faster, efficient, ...